Search by Drug Name or NDC
NDC 13668-0397-30 Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg 5; 12.5; 20 mg/1; mg/1; mg/1 Details
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg 5; 12.5; 20 mg/1; mg/1; mg/1
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.
MedlinePlus Drug Summary
Amlodipine is used alone or in combination with other medications to treat high blood pressure in adults and children 6 years and older. It is also used to treat certain types of angina (chest pain) and coronary artery disease (narrowing of the blood vessels that supply blood to the heart). Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart. If taken regularly, amlodipine controls chest pain, but it does not stop chest pain once it starts. Your doctor may prescribe a different medication to take when you have chest pain. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 13668-0397-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Amlodipine
Hydrochlorothiazide is used alone or in combination with other medications to treat high blood pressure. Hydrochlorothiazide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease and to treat edema caused by using certain medications including estrogen and corticosteroids. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 13668-0397-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Hydrochlorothiazide
Olmesartan is used alone or in combination with other medications to treat high blood pressure in adults and children 6 years of age and older. Olmesartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 13668-0397-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Olmesartan
Product Information
| NDC | 13668-0397 |
|---|---|
| Product ID | 13668-397_1ae8e8eb-da85-4790-8b02-a34f95c122f0 |
| Associated GPIs | 36994503450310 |
| GCN Sequence Number | 066538 |
| GCN Sequence Number Description | olmesartan/amlodipin/hcthiazid TABLET 20-5-12.5 ORAL |
| HIC3 | A4V |
| HIC3 Description | ANGIOTEN.RECEPTR ANTAG-CALCIUM CHANL BLKR-THIAZIDE |
| GCN | 28837 |
| HICL Sequence Number | 037089 |
| HICL Sequence Number Description | OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE/HYDROCHLOROTHIAZIDE |
| Brand/Generic | Generic |
| Proprietary Name | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 20/5/12.5 mg |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5; 12.5; 20 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Pharmaceutical Class | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], In |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203580 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 13668-0397-30 (13668039730)
| NDC Package Code | 13668-397-30 |
|---|---|
| Billing NDC | 13668039730 |
| Package | 30 TABLET in 1 BOTTLE (13668-397-30) |
| Marketing Start Date | 2016-10-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.35808 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |